이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Edan Instruments 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Hao Zhang

최고 경영자

CN¥2.0m

총 보상

CEO 급여 비율	n/a
CEO 임기	14.3yrs
CEO 소유권	21.1%
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	12.9yrs

최근 관리 업데이트

Recent updates

CEO

Hao Zhang (60 yo)

14.3yrs

테뉴어

CN¥2,016,900

보상

Mr. Hao Zhang serves as the Chairman and President at Edan Instruments, Inc. Mr. Zhang has a Master’s Degree.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Hao Zhang	Chairman & President	14.3yrs	CN¥2.02m	21.05% CN¥ 1.0b
Youdong Zu	CFO, VP	14.3yrs	CN¥1.62m	17.27% CN¥ 842.9m
Xicheng Xie	VP & Non-Independent Director	14.3yrs	CN¥1.62m	17.18% CN¥ 838.4m
Yang Su	Independent Director	14.3yrs	CN¥150.00k	데이터 없음
Chun Zhou	Chairman of Supervisory Board	11.4yrs	CN¥98.80k	데이터 없음
Chun Li	Independent Director	14.3yrs	CN¥150.00k	데이터 없음
Hongchao Wang	Non-Employee Supervisor	5.7yrs	데이터 없음	데이터 없음
Quanlu Zheng	Independent Director	2.3yrs	CN¥150.00k	데이터 없음
Yirong Zhou	Non-Employee Supervisor	4.2yrs	데이터 없음	데이터 없음
Shixin Yuan	Independent Outside Director	1.3yrs	CN¥104.20k	데이터 없음

12.9yrs

평균 재임 기간

59.5yo

평균 연령

경험이 풍부한 이사회: 300206 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 12.8 년).

Edan Instruments 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Edan Instruments, Inc., Annual General Meeting, Apr 22, 2024

High number of new directors

High number of new directors

Recent updates

Edan Instruments, Inc. to Report First Half, 2024 Results on Aug 30, 2024

First quarter 2024 earnings released: EPS: CN¥0.066 (vs CN¥0.24 in 1Q 2023)

Edan Instruments, Inc. to Report Q1, 2024 Results on Apr 26, 2024

Edan Instruments, Inc., Annual General Meeting, Apr 22, 2024

Full year 2023 earnings released: EPS: CN¥0.38 (vs CN¥0.40 in FY 2022)

New minor risk - Share price stability

Investor sentiment improves as stock rises 33%

Investor sentiment deteriorates as stock falls 16%

Edan Instruments, Inc. to Report Fiscal Year 2023 Results on Mar 29, 2024

Edan Instruments, Inc. Focus on Medical Technology Advancement Shines At Medica 2023

New minor risk - Earnings quality

Third quarter 2023 earnings released: EPS: CN¥0.051 (vs CN¥0.068 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.17 in 2Q 2022)

Edan Instruments, Inc. to Report First Half, 2023 Results on Aug 23, 2023

First quarter 2023 earnings released: EPS: CN¥0.24 (vs CN¥0.085 in 1Q 2022)

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings released: EPS: CN¥0.068 (vs CN¥0.11 in 3Q 2021)

Edan Instruments, Inc. Showcases Its First Molecular Diagnostics Analysis System, ClariLight CL30, at Medlab Asia & Asia Health 2022

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.17 (vs CN¥0.10 in 2Q 2021)

Edan Instruments, Inc. Launches i20

High number of new directors

High number of new directors

First quarter 2022 earnings released: EPS: CN¥0.085 (vs CN¥0.21 in 1Q 2021)

Edan Instruments, Inc. Announces Cash Dividend for the Year 2021, Payable on 29 April 2022

Edan Instruments, Inc. Approves Distribution for 2021

Investor sentiment deteriorated over the past week

Third quarter 2021 earnings released: EPS CN¥0.11 (vs CN¥0.28 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.10 (vs CN¥0.67 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.14 in 1Q 2020)

Edan Instruments, Inc. Announces Profit Distribution Proposal for 2020

Full year 2020 earnings released: EPS CN¥1.12 (vs CN¥0.23 in FY 2019)

Investor sentiment deteriorated over the past week

Edan Instruments, Inc. to Report Fiscal Year 2020 Results on Mar 15, 2021

CEO

테뉴어

보상

이사회 구성원

평균 재임 기간

평균 연령